Eric C. Peterson

High Impact

Professor

UAMS

Last publication 2025 Last refreshed 2026-05-22

faculty

Pharmacology & Toxicology, College of Medicine

38 h-index 155 pubs 5,239 cited

Research Areas

Links

ORCID Lab Website Research Group UAMS TRI Profile

OverviewAI-generated summary

Eric C. Peterson is a Professor in the Department of Pharmacology & Toxicology at the University of Arkansas for Medical Sciences. His scholarly work has resulted in 157 publications and 5,358 citations, with an h-index of 38. He has been recognized as a highly cited researcher.

Peterson's research focuses on the outcomes of endovascular treatments for emergent large vessel occlusions, including mechanical thrombectomy and embolization for conditions such as stroke and dural arteriovenous fistulas. He has investigated the role of thrombi composition, specifically netosis and inflammasomes, in large vessel occlusions. His work also examines the differential expression of inflammatory and angiogenic factors in plasma following acute large vessel occlusion stroke.

His funded research includes a $270,624 award from the NIH/National Cancer Institute as Co-PI for the Cancer and Developing Entrepreneurial Technologies (CADET) project. Peterson leads a research group and maintains an active lab website, and collaborates with several colleagues at the University of Arkansas for Medical Sciences, including Erich A. Peterson, Donald J. Johann, Ikjae Shin, and Matthew A. Steliga.

Metrics

h-index: 38
Publications: 155
Citations: 5,239

Selected Publications

Case 3: An Uncommon Cause of Respiratory Distress in a Term Newborn (2025)

DOI OpenAlex
A functional surface display system in Saccharomyces boulardii for protein absorption in simulated intestinal fluids (2025)

DOI OpenAlex
Antagonizing the SAMD9 pathway is key to myxoma virus host shut-off and immune evasion (2024)

1 citation DOI OpenAlex
Liquid biopsy based on circulating tumor DNA for lung cancer: A step toward prevention (2023)

DOI OpenAlex
An advanced molecular medicine case report of a rare human tumor using genomics, pathomics, and radiomics (2023)

5 citations DOI OpenAlex
Effect of Antigen Retrieval on Genomic DNA From Immunodissected Samples (2022)

4 citations DOI OpenAlex
Myxoma virus lacking the host range determinant M062 stimulates cGAS-dependent type 1 interferon response and unique transcriptomic changes in human monocytes/macrophages (2022)

13 citations DOI OpenAlex
Abstract 5038: Applying reproducible genomic data science methods for the analysis of a rare tumor type (2022)

1 citation DOI OpenAlex
Microdissection Methods Utilizing Single-Cell Subtype Analysis and the Impact on Precision Medicine (2022)

2 citations DOI OpenAlex
Myxoma virus lacking the host range determinant M062 stimulates cGAS-dependent type 1 interferon response and unique transcriptomic changes in human macrophages (2022)

4 citations DOI OpenAlex
NPARS—A Novel Approach to Address Accuracy and Reproducibility in Genomic Data Science (2021)

4 citations DOI OpenAlex
Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed (2021)

13 citations DOI OpenAlex
Exogenous phosphatidic acid reduces acetaminophen-induced liver injury in mice by activating hepatic interleukin-6 signaling through inter-organ crosstalk (2021)

21 citations DOI OpenAlex
Synergizing microdissection with ddPCR to advance precision oncology. (2021)

1 citation DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 1 $270,624 total

NIH/National Cancer Institute Co-PI Sep 2025 - Aug 2030

Cancer and Developing Entrepreneurial Technologies (CADET)

National Cancer Institute $270,624 R25

Grants & Funding

Cancer and Developing Entrepreneurial Technologies (CADET) NIH/Nat. Cancer Institute Principal Investigator
No FP attached UAMS College of Medicine Principal Investigator
Cancer and Developing Entrepreneurial Technologies (CADET) NIH Co-Principal Investigator
Active Immunization for Treating Methamphetamine Abuse NIH/Nat. Inst. on Drug Abuse Co-Investigator
Pharmacology and Therapy for MDPV and alpha-PVP Like Drugs of Abuse NIH/Nat. Inst. on Drug Abuse Co-Investigator
Antibody-based Therapy for Methamphetamine Abuse NIH/Nat. Inst. on Drug Abuse Co-Investigator
Cancer and Developing Entrepreneurial Technologies (CADET) NIH/Nat. Cancer Institute Principal Investigator
Cancer and Developing Entrepreneurial Technologies (CADET) NIH/Nat. Cancer Institute Principal Investigator